DNA Repair Drugs: A Promising New Class of Cancer Treatments


All cells experience DNA damage on a regular basis from various environmental and endogenous sources such as radiation, chemicals, and reactive oxygen species produced during normal cellular metabolism. Under normal circumstances, cells have robust DNA repair mechanisms that detect and fix alterations to the DNA structure before they can lead to mutations.

One of the most clinically advanced classes of DNA Repair Drugs are PARP (Poly ADP-Ribose Polymerase) inhibitors. PARP enzymes play an important role in repairing single-strand DNA breaks through the base excision repair pathway.

Get more insights: DNA Repair Drugs (https://articlescad.com/dna-repair-drugs-a-promising-new-class-of-cancer-therapies-67552.html)

#CoherentMarketInsights #DNARepairDrugs #Niraparib #Olaparib #Rucaparib #Talazoparib #OvarianCancer #BreastCancer #ProstateCancer #LungCancer #PeritonealCancer
DNA Repair Drugs: A Promising New Class of Cancer Treatments All cells experience DNA damage on a regular basis from various environmental and endogenous sources such as radiation, chemicals, and reactive oxygen species produced during normal cellular metabolism. Under normal circumstances, cells have robust DNA repair mechanisms that detect and fix alterations to the DNA structure before they can lead to mutations. One of the most clinically advanced classes of DNA Repair Drugs are PARP (Poly ADP-Ribose Polymerase) inhibitors. PARP enzymes play an important role in repairing single-strand DNA breaks through the base excision repair pathway. Get more insights: DNA Repair Drugs (https://articlescad.com/dna-repair-drugs-a-promising-new-class-of-cancer-therapies-67552.html) #CoherentMarketInsights #DNARepairDrugs #Niraparib #Olaparib #Rucaparib #Talazoparib #OvarianCancer #BreastCancer #ProstateCancer #LungCancer #PeritonealCancer
0 Comments 0 Shares